The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
Strengthening capabilities in Peptide Therapeutics and CDMO services
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
This acquisition positions Suven as a key player in one of the fastest growing segments of the Pharma CDMO landscape
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
Subscribe To Our Newsletter & Stay Updated
